Medline Adds Award-winning IDENTI Medical Sensing Solutions to its Supply Chain Portfolio

Offers first wireless weight-based PAR bins in the U.S.

Responding to increased healthcare provider demand for digital and scalable inventory management solutions, Medline has enhanced its supply chain optimization (SCO) portfolio with a new partnership with IDENTI Medical.

A dynamic and global leader in point-of-use data sensing solutions, IDENTI Medical designs, develops and produces advanced data collection solutions for surgery, procedure and clean supply room settings.  Last year, Netanya-headquartered IDENTI ranked in the top 100 fastest growing companies in Israel, while its SNAP & GO™ image recognition technology won the 2022 Frost & Sullivan Best New Product Innovation Award.

SNAP & GO maximizes the efficiencies in ORs and procedure rooms, while increasing patient safety by digitally recording product information and usage at the point of use. Complete unique device identification tracking is recorded directly into the patient’s electronic file, saving time for busy clinical staff and achieving full data and charge capture in seconds.

In addition, IDENTI recently launched the first-of-its-kind in the U.S. wireless, weight-based and self-requisition PAR bin– garnering major industry interest and accolades. The bin’s wireless feature marks the next generation of PAR supplies management as the bin are completely wireless and can be placed wherever most needed.

“As prime vendor and preferred supplier to top healthcare systems and providers around the U.S., Medline provides the resources, distribution programs and access to technology to enable end-to-end inventory models of visibility – from distribution centers to point-of-use,” said John Ramirez, Medline senior director of supply chain. “IDENTI’s global success, expertise and technology will go a long way in helping us deliver impactful supply chain solutions in the healthcare industry.”

IDENTI is also well known globally for its clinician-friendly solutions for tissue and implant tracking, medical supplies replenishment and management systems for controlled substances and narcotics – boosting patient safety and improving business processes.

“At our core, we apply state-of-the-art technology including AI, machine learning, RFID and image recognition technology to help providers achieve more control over their medical inventory and improve patient outcomes,” said Shlomo Matityaho, chief executive officer of IDENTI, “And, we’re thrilled to have an agile and forward-thinking partner in Medline, whose commitment to bring forward to its customers the top healthcare tech and resources in the world is clearly driving Medline’s remarkable growth.” More here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”